The degradation of cellular components in lysosomes through autophagy has a central role in essential cellular functions that range from the maintenance of cell homeostasis, prevention of the accumulation of damaged proteins and recycling of amino acids for new protein synthesis to the regulation of cell differentiation, protection against biological, physical or chemical stress and regulation of cell death and survival 1,2 . Three main forms of autophagy have been described in mammalian cells, macroautophagy, microautophagy and chaperone-mediated autophagy (CMA), which use different mechanisms to target substrates into the lysosome and are also regulated differently. CMA is a selective form of autophagy that targets single soluble cytosolic proteins bearing a consensus targeting motif biochemically related to the pentapeptide Lys-Phe-Glu-Arg-Gln (KFERQ) 3 . The substrates of CMA are recognized by the cytosolic heatshock chaperone hsc70 and its associated co-chaperones, which deliver the substrate proteins to the lysosomal membrane 4 . The mRNA from the gene Lamp2 undergoes alternative splicing and generates three different single-span membrane proteins, LAMP-2A, LAMP-2B and LAMP-2C, which have different carboxy-terminal domains. Only LAMP-2A is involved in CMA 5 . LAMP-2A is the lysosomal receptor for CMA and mediates the translocation of substrates into the lysosomal lumen assisted by a lumen-resident form of hsc70 (refs. 6,7). CMA activity is directly dependent on the amount of LAMP-2A at the lysosomal membrane because the binding of substrate proteins to LAMP-2A is the limiting step in the CMA pathway 5, 8 . Lysosomal amounts of LAMP-2A are usually regulated through changes in its turnover and intralysosomal distribution and do not usually involve de novo protein synthesis 8, 9 . However, under conditions requiring maximal activation of this autophagic process, such as in response to oxidative stress, activation of CMA occurs through upregulation of Lamp2 transcription and the de novo synthesis of LAMP-2A protein 10 .
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T cell activation requires tight regulation of positive and negative modulators of signaling pathways downstream of the T cell antigen receptor (TCR). The ability of CMA to selectively degrade specific proteins makes this type of autophagy a possible candidate to contribute to the regulation of the abundance of different signaling intermediates during T cell activation. CMA contributes to the regulation of cellular 'quality control' and the response to stress in several tissues and organs [10] [11] [12] ; however, there is as yet very little evidence of what role, if any, CMA might have in regulation of the adaptive immune system. In this study we present evidence that CMA is an essential regulator of T cell activation through the targeted degradation of the ubiquitin ligase Itch and the calcineurin inhibitor RCAN1, two negative regulators of TCR signaling. Consequently, activation of CMA in response to engagement of the TCR helped maintain activation-induced T cell responses. Furthermore, we found that an age-dependent decrease in CMA activity in T cells seemed to underlie the deficient T cell function associated with aging. modulation of T cell responses and is induced in response to T cell activation, we investigated whether expression of LAMP-2A changed in response to engagement of the TCR. Immunoblot analysis showed a marked increase in the amount of LAMP-2A in total cell lysates in various subsets of CD4 + T cells, including naive and effector cells, following activation with antibody to the invariant signaling protein CD3 (anti-CD3) in the presence or absence of antibody to the coreceptor CD28 (anti-CD28) (Fig. 1a) . We saw an increase in LAMP-2A expression in T cells activated with anti-CD3 in the absence of anti-CD28, which suggested that the process was not dependent on costimulation, although engagement of CD28 appeared to accelerate the kinetics by which LAMP-2A expression was induced (Fig. 1a) . Increased expression of LAMP-2A protein in activated T cells correlated with upregulation of the expression of Lamp2a mRNA (Fig. 1b) . Immunofluorescence analysis with anti-LAMP-2A also showed more LAMP-2A + puncta, which distributed in a characteristic lysosomal pattern, in T cells activated for 24 h than in resting T cells (Fig. 1c) . An increased number of lysosomes was also indicated by morphometric analysis of electron microscopy images, which showed that activated T cells had more electrodense lysosomes per cell than did 
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Recovery (%) A r t i c l e s resting T cells (Fig. 1d) . However, the increase in the number of lysosomes in activated T cells was not dependent on LAMP-2A, as we detected a similar increase in lysosomes in LAMP-2A-deficient T cells, through use of a lysosomal probe (Supplementary Fig. 1a) .
As the transcription factor TFEB has been identified as a key regulator of lysosomal biogenesis 15 and its expression has been reported in activated T cells 16 , we investigated whether induction of TFEB expression in activated T cells might account for the increased lysosomal biogenesis in these cells. Expression of TFEB was upregulated in activated CD4 + T cells (Supplementary Fig. 1b) . Knockdown of TFEB expression with TFEB-specific small interfering RNA (siRNA) markedly reduced the increase in lysosomal numbers induced by the engagement of TCR-CD28 in CD4 + T cells ( Supplementary  Fig. 1c-e) , which suggested that, as has been described for macroautophagy 17 , TFEB may, in some conditions, link lysosomal biogenesis and CMA activation.
To determine if the increase in the amount of LAMP-2A in lysosomes resulted in higher CMA activity, we differentiated CD4 + type 1 helper T cells (T H 1 cells) in vitro and then transfected them with a vector that directs the expression of KFERQ-PA-mCherry-1, a photoactivable CMA reporter 18, 19 that allows monitoring of CMA activity in living cells. In this experimental system, photoactivation of the KFERQ-mCherry-1 reporter allows detection of CMA activation as red punctate patterns that result from redistribution of the fluorescent CMA substrate from the cytosol to the lysosomes membrane. The activation of T cells with anti-CD3 and anti-CD28 significantly increased the number of mCherry + puncta per cell (Fig. 1e) , which further supported the proposal that engagement of the TCR induced CMA activation. Treatment with 3-methyladenine, an inhibitor of macroautophagy with no effect on CMA 18, 19 , did not affect cellular redistribution of the red fluorescent protein mCherry (Fig. 1e) . Furthermore, a control photoactivable mCherry-1 protein that does not express a functional CMA-targeting KFERQ motif did not undergo lysosomal redistribution in activated T cells (data not shown).
CMA occurs only at lysosomes that express the resident chaperone hsc70, which is required for the translocation of substrate proteins into lysosomes, in their lumen 20 . This subgroup of lysosomes usually expands in number when CMA is maximally activated. We then investigated whether activated T cells showed enrichment for hsc70 + lysosomes. Immunoblot analysis of lysosomal fractions showed more hsc70 in the lysosomes of activated T cells than in those of resting T cells (Fig. 1f) , which suggested expansion of the CMAactive population of lysosomes following T cell activation. T cells with higher expression of LAMP2A following activation (Fig. 1a) also increased the size of their lysosomal compartment (Fig. 1c) and thus the amount of LAMP-2A protein per lysosome did not change (Fig. 1f) . Collectively, these results indicated that engagement of the TCR activated CMA activity in CD4 + T cells through the upregulation of LAMP-2A expression.
ROS regulate TCR-induced LAMP-2A expression
Because mild oxidative stress activates CMA in fibroblasts through transcriptional upregulation of Lamp2 (ref. 10), we next explored whether the production of reactive oxygen species (ROS) following T cell activation was responsible for the increased LAMP-2A expression in T cells. T cells treated with N-acetylcysteine, a ROS scavenger, failed to increase their expression of LAMP-2A protein (Fig. 1g) or Lamp2a mRNA (Fig. 1h) following activation. A luciferase reporter vector controlled by the proximal promoter of Lamp2 was sensitive to activation with anti-CD3 and anti-CD28, and cells transfected with this vector showed an increase in luciferase activity with kinetics similar to the induction of the expression of endogenous Lamp2a mRNA in activated T cells (Fig. 1i) . In addition, increased luciferase activity was also induced by the oxidative stress-inducing agent paraquat and by treatment with hydrogen peroxide (Fig. 1j) , which indicated the presence of ROS-responsive elements in the Lamp2 proximal promoter. ROS generated in the mitochondria and cytosol are known to be required for efficient TCR engagement-induced store-operated calcium signaling 21, 22 . To further investigate the role of ROS in the TCR-dependent induction of Lamp2 transcription, we knocked down the expression of two enzymes, RISP and Duox1, that regulate TCR signaling through mitochondrial ROS production and cytosolic ROS production, respectively 21, 22 ( Supplementary Fig. 1f,g ). Activated T cells expressing siRNA specific for either RISP or Duox1 had much lower expression of LAMP-2A protein than that of control cells transfected with nontargeting siRNA (Fig. 1k) . One of the main signaling targets of store-operated calcium entry is calcineurin-mediated activation of the transcription factor NFAT. Inhibition of the TCRinduced generation of ROS results in less translocation of NFAT to the nucleus in T cells 22 . We identified several putative NFAT-binding sites in the Lamp2 proximal promoter (data not shown), which suggested that ROS might induce Lamp2 expression through NFAT. Furthermore, TCR-induced expression of LAMP-2A was prevented by the calcineurin inhibitor cyclosporine A (Fig. 1l) , and through the use of chromatin immunoprecipitation, we detected specific binding of NFAT1, the most abundant NFAT protein in effector helper T cells 23 , at the Lamp2 promoter in activated T H 1 cells (Fig. 1m) , which suggested a direct role for NFAT in the TCR-induced expression of Lamp2. Binding of NFAT1 to the Lamp2 promoter was also prevented by cyclosporine A (Supplementary Fig. 1h ). These results suggested that TCR-induced ROS production modulated Lamp2 expression in CD4 + T cells through activation of NFAT.
CMA activity maintains T cell activation
To determine the importance of CMA during the activation of T cells, we investigated the effects of silencing Lamp2a mRNA (and therefore inhibiting CMA) in T cells. We transduced T H 1 cells with retrovirus expressing control (nontargeting) or Lamp2a mRNA-specific short hairpin RNA (shRNA) and green fluorescent protein (GFP) and sorted the cells on the basis of GFP expression (Fig. 2a) . Silencing of Lamp2a expression significantly reduced both the activation-induced cytokine production ( Fig. 2b) and proliferation ( Fig. 2c) of T H 1 cells. We confirmed the specificity of this effect with three shRNAs targeting different regions of Lamp2a mRNA ( Supplementary Fig. 2a-c) . Furthermore, a vector expressing human LAMP-2A, which is not targeted by the shRNA we used, restored LAMP-2A expression in T cells in which Lamp2a mRNA was silenced and restored cytokine production and proliferative responses to levels similar to those of control cells expressing the nontargeting shRNA ( Supplementary  Fig. 2a-c) . The impaired T cell responses caused by the silencing of Lamp2a mRNA were not due to increased apoptosis, as T cells in which Lamp2a mRNA was silenced and control T cells expressing the nontargeting shRNA showed no significant difference in their binding of annexin V (Fig. 2d) . These data indicated that LAMP-2A expression was needed to maintain T cell activation.
Degradation of Itch and RCAN1 by CMA in activated T cells
To investigate how CMA regulated T cell activation, we investigated whether CMA was required for the selective degradation of inhibitors of TCR signaling. CMA is a selective form of autophagy in which npg substrate specificity is conferred by the presence, in the substrate protein, of a pentapeptide motif with biochemical properties comparable to those of KFERQ, which allows recognition of the substrate by cytosolic hsc70 (ref. 3). We screened candidate proteins with a previously defined negative regulatory effect on TCR signaling for the presence of one or more motifs in their amino acid sequences that would target them for CMA. We identified the presence of three such motifs in the E3 ubiquitin ligase Itch and the calcineurin inhibitor RCAN1 (data not shown), which has been defined as a CMA substrate in neurons 24 . The lysosomal fractions of activated T cells showed enrichment for both proteins (Fig. 3a) , which suggested that they were being targeted to the lysosome for degradation following activation. We also detected a faster migrating band specific for RCAN1, which probably represented a smaller isoform of RCAN1 (ref. 25) , by immunoblot analysis of lysosomes isolated from activated cells (Fig. 3a) . To determine if Itch and RCAN1 proteins were degraded in the lysosomes, we measured lysosomal Itch and RCAN1 in T cells activated in the presence or absence of lysosomal protease inhibitors. The lysosomal fractions of activated T cells showed enrichment for both RCAN1 and Itch in the presence of protease inhibitors relative to their abundance in untreated cells (Fig. 3b) , which suggested lysosomal degradation in activated T cells. Furthermore, N-acetylcysteine, which prevented the upregulation of LAMP-2A expression, caused defective degradation of Itch in activated T cells (Fig. 3c) .
Expression of RCAN1 is reported to be upregulated in activated T cells 26 . Following such upregulation, RCAN1 was also degraded in T H 1 cells (Supplementary Fig. 3a) , probably to maintain the cellular homeostasis of this protein. Treatment of activated T cells with N-acetylcysteine impaired the degradation of RCAN1, which resulted in a greater abundance of RCAN1 than in cells activated in the absence of N-acetylcysteine (Fig. 3c) .
To confirm that Itch and RCAN1 were substrates of CMA, we generated mutant versions of all putative motifs that might target these proteins for CMA. We transfected T H 1 cells with plasmid expressing wild-type Itch tagged with GFP (GFP-Itch) or wild-type RCAN1 tagged with Myc (Myc-RCAN1) or their mutant counterparts (GFPmu-Itch or Myc-mu-RCAN1, respectively) and then activated the cells for 24 h with anti-CD3 and anti-CD28. The expression of wild-type and mutant Itch and RCAN1 was similar to that of the endogenous proteins also expressed in the transfected T cells ( Supplementary  Fig. 3b,c) . GFP-mu-Itch and Myc-mu-RCAN1 showed more accumulation in activated T cells than did GFP-Itch or Myc-RCAN1 ( Fig. 3d and Supplementary Fig. 3b-e) . This accumulation was not a consequence of differences in the efficiency of transfection because we detected similar expression of GFP expressed from a cotransfected reporter vector in all conditions (Fig. 3d) . In addition, GFP-mu-Itch and Myc-mu-RCAN1 were not efficiently targeted to the lysosomal compartment ( Supplementary Fig. 3f,g ). Transfection of GFP-mu-Itch or Myc-mu-RCAN1 suppressed activation-induced T cell proliferation ( Fig. 3e) and cytokine production (Fig. 3f) more than did transfection of their wild-type counterparts. These results indicated that degradation of Itch and RCAN1 by CMA was needed to maintain efficient T cell activation.
LAMP-2A deficiency diminishes adaptive immune responses
To analyze the function of CMA in T cells in vivo, we used a newly generated mouse model in which Lamp2a mRNA expression was specifically prevented in T cells. We crossed C57BL/6 mice expressing exon 8a of Lamp2 flanked by loxP sites 27 with C57BL/6 mice expressing Cre recombinase under the control of the promoter of the gene encoding the tyrosine kinase Lck. In the progeny of these mice (called 'L2A-cKO mice' here), deletion of exon 8a prevents the expression of Lamp2a mRNA (encoding LAMP-2A, the only LAMP-2 isoform that acts as a receptor for CMA), while expression of mRNA encoding the other two Lamp2 splicing variants, LAMP-2B (Lamp2b mRNA) and LAMP-2C (Lamp2c mRNA), is preserved. L2A-cKO mice showed specific loss of LAMP-2A expression in the T cell compartment, while its expression was normal in other tissues (Fig. 4a) . Real-time PCR analysis confirmed loss of expression of Lamp2a mRNA in T cells in L2A-cKO mice, while their expression of Lamp2b mRNA and Lamp2c mRNA was similar to that of their control littermates, which had loxP-flanked Lamp2 exon 8a but did not express Cre (Fig. 4b) . Macroautophagy was not impaired in CD4 + T cells in L2A-cKO mice (Fig. 4c) , which indicated the existence of a normal functional lysosomal compartment. Basal macroautophagy activity was slightly higher in LAMP-2A-deficient T cells than in LAMP-2A-sufficient T cells (Fig. 4c) , probably due to the reported compensatory effect of these two forms of autophagy 28 , while activation-induced macroautophagy was similar in LAMP-2A-sufficient and LAMP-2A-deficient T cells (Fig. 4c) . Furthermore, the expression of lysosomal structural proteins (LAMP-1), lysosomal proteases and glycosidases (cathepsin D and β-hexosaminidase), as well as lysosomal stability were not lower in LAMP-2A-deficient T cells than in LAMP-2A-sufficient T cells (Supplementary Fig. 4a-c) . A r t i c l e s LAMP-2A-deficient mice had a smaller spleen and thymus than that of than in LAMP-2A-sufficient mice, with fewer total thymocytes and a 20-30% lower frequency of peripheral CD4 + and CD8 + T cells but conserved numbers of CD4 + CD25 + T cells (Fig. 4d and Supplementary Fig. 4 ). L2A-cKO mice also had a slightly higher frequency of CD4 − CD8 − (double-negative) thymocytes than their control littermates had, but no major differences in other thymic populations were apparent (Supplementary Fig. 4d-f) . Cell death in the spleen and thymus of L2A-cKO mice was similar to that in their control littermates (data not shown). Furthermore, peripheral LAMP-2A-deficient CD4 + T cells did not appear to have any defect in early signaling events downstream of the TCR ( Supplementary  Fig. 5a-d) .
As noted in vitro, CD4 + T cells isolated from L2A-cKO mice showed impaired T cell responses, with significantly less activationinduced proliferation and lower cytokine expression than that of cells from their control littermates (Fig. 4e,f) . Expression of RCAN1 and Itch protein was much higher in T cells from L2A-cKO mice than in T cells from their control littermates (Fig. 4g) , and this was not a consequence of differences in the expression of Rcan1 mRNA or Itch mRNA in LAMP-2A-deficient T cells relative to their expression in LAMP-2A-sufficient T cells (Fig. 4h) . Furthermore, we observed less RCAN1 and Itch in the lysosomal compartment of LAMP-2A-deficient T cells than in that of LAMP-2A-sufficient T cells, and whereas overexpression of Myc-mu-RCAN1 resulted in accumulation of the mutant RCAN1 protein in wild-type cells, Myc-RCAN1 and Myc-mu-RCAN1 accumulated similarly in LAMP-2A-deficient T cells ( Supplementary  Figs. 3h and 5e,f) .
To further analyze the role of CMA in the regulation of T cell function in vivo, we measured T cell responses in two different experimental models. First, we immunized mice with peptide of amino acids 323-339 of ovalbimun protein (OVA(323-339); two immunizations separated by 1 week). At 7 d after the second immunization, we isolated draining lymph nodes and analyzed recall responses to OVA(323-339). Cell proliferation as well as cytokine production in response to rechallenge with OVA(323-339) were significantly lower in L2A-cKO mice than in their control littermates (Fig. 4i,j) . Furthermore, anti-OVA(323-339)-specific immunoglobulin in serum was significantly lower in immunized L2A-cKO mice than in their immunized control littermates (Supplementary Fig. 4g) . In a second model, we challenged L2A-cKO mice and their control littermates intraperitoneally with attenuated Listeria monocytogenes. We found that at 7 d after that injection, CD4 + T cells isolated from spleen of L2A-cKO mice proliferated less and showed significantly lower cytokine production than did those isolated from their control littermates after rechallenge ex vivo with L. monocytogenes-infected antigen-presenting cells (Fig. 4k,l) , while titers antibodies specific to L. monocytogenes were lower in the serum of infected L2A-cKO mice than in that of their infected control littermates ( Supplementary  Fig. 4h) . Furthermore, when mice were rechallenged in vivo with a high dose of L. monocytogenes, L2A-cKO mice were less efficient in controlling this pathogen than were their control littermates, which resulted in higher titers of L. monocytogenes in the spleen and liver of the L2A-cKO mice (Fig. 4m) . Together these data indicated that CMA activity in T cells was needed to generate effective in vivo T cell responses.
Deficient CMA with aging diminishes T cell responses
Because one of the best characterized physiological conditions in which CMA activity is reduced is aging 29 , we investigated whether a diminution in CMA occurred in T cells with aging and could account for the diminished T cell responses observed in aging organisms. Effector T cells differentiated from naive cells isolated from aged mice failed to efficiently upregulate their expression of LAMP-2A in response to engagement of the TCR (Fig. 5a) . Consequently, we detected higher expression of Itch protein (40%) and RCAN1 protein (15%) in activated T cells from 22-month-old mice than in activated T cells from 4-month old mice, although that difference was significant only for Itch (Fig. 5b) . Freshly isolated naive and memory CD4 + T cells isolated from young mice responded to activation of the TCR with increased LAMP-2A expression, although such upregulation was less pronounced in memory T cells than in naive T cells (Fig. 5c) . Naive CD4 + T cells from 22-month-old mice showed significant impairment in their ability to upregulate LAMP-2A expression compared with that of naive CD4 + T cells from younger, 4-monthold mice, whereas this defect was not as evident in memory T cells (Fig. 5d) . Itch and RCAN1 accumulated in naive T cells isolated from old mice (Supplementary Fig. 5g ), which also showed decreased activation-induced translocation of NFAT to the nucleus (Fig. 5e) . Furthermore, whereas as expected, naive CD4 + T cells isolated from 22-month-old mice had greater basal production of ROS than that of naive CD4 + T cells from younger mice, they were nonetheless less able to increase ROS expression upon engagement of the TCR ( Fig. 5f and Supplementary Fig. 5h ). Memory CD4 + T cells also showed some age-associated accumulation of Itch and RCAN1, although the total cellular amount of these proteins was much lower than that detected in naive cells (Supplementary Fig. 5g ).
To determine the functional relevance of decreased activation of CMA in T cells with age, we analyzed the consequences of restoring the expression of LAMP-2A in T cells from old mice (Fig. 5g) . T cells from old mice were less responsive to engagement of the TCR and showed lower proliferation and cytokine expression than did T cells from young mice (Fig. 5h,i) . However, in effector CD4 + T cells from 22-month-old mice transduced with a LAMP-2A-expressing retrovirus, activation-induced cell proliferation and cytokine production were both restored to levels similar to those detected in T cells from 4-month-old mice transduced with either with control retrovirus expressing GFP or virus expressing LAMP-2A (Fig. 5h-i) .
We also assessed the ability of human CD4 + T cells to upregulate their expression of LAMP-2A in response to activation. We isolated CD4 + T cells from 'leukopaks' (enriched leukapheresis products collected from normal peripheral blood) obtained from anonymous donors and found that activation of the cells for 24 or 48 h with beads coated with anti-CD3 and anti-CD28 also increased the expression of LAMP-2A (Fig. 5j) . We also isolated naive and memory CD4 + T cells from whole blood of young subjects (26 ± 2 years of age) and old subjects (78 ± 6 years of age) and activated the cells for 24 h with beads coated with anti-CD3 and anti-CD28, then analyzed the activation-induced expression of mRNA encoding LAMP-2A (LAMP2A mRNA). Naive T cells from old subjects showed a significant defect in the induction of LAMP2A mRNA following activation compared with that of T cells from young subjects (Fig. 5k) . As seen in mice, memory CD4 + T cells from young human subjects also showed a less pronounced induction of LAMP2A mRNA than did naive cells (Fig. 5k) . In addition, memory T cells from old subjects also showed significantly less ability to upregulate their expression of LAMP2A mRNA than did those from their young counterparts (Fig. 5k) . Together these data indicated that decreased CMA activity with age was a determinant factor for T cell immunosenescence. Fig. 2c (e) or Fig. 2b (f) ). *P = 0.0062 (e) or 0. A r t i c l e s DISCUSSION CMA contributes to the maintenance of cellular homeostasis during prolonged starvation 30 and to cellular 'quality control' in response to various stressors, such as oxidative stress 10 . The unique selectivity of this type of autophagy confers also important regulatory functions through the selective degradation of individual proteins in a tightly regulated manner 31, 32 . Here we have described a regulatory role for CMA in helper T cells. Our data have shown that in response to engagement of the TCR, CD4 + T cells activated CMA through the upregulation of LAMP-2A expression. In activated T cells, CMA directed the degradation of two negative regulators of TCR signaling, Itch and RCAN1, which allowed the generation of effective T cell responses.
The activation of T cells leads to the mitochondrial generation of ROS, which are needed to ensure the activation of NFAT and production of interleukin 2 (IL-2) 22 . Furthermore, the NADPH oxidase Duox1 couples the generation of H 2 O 2 with signaling events downstream of the TCR and contributes to store-operated calcium entry and NFAT activation in CD4 + T cells 21 . Our data indicated that NFAT1 was recruited to the Lamp2 promoter in activated T cells and that Lamp2 upregulation in those cells was prevented by the calcineurin inhibitor cyclosporine A or by blockade of ROS production, which supports the proposal that activation of NFAT activated by ROS and mediated by calcium-calcineurin upregulates Lamp2 expression and activates CMA following engagement of the TCR.
Basal macroautophagy maintains organelle homeostasis in T cells 33, 34 . Macroautophagy is also activated in response to engagement of the TCR and regulates cell proliferation, energy metabolism and cell death 13, 14 . Selective macroautophagy also regulates TCR signaling by targeting ubiquitinated Bcl-10 (a component of the complex that activates the kinase IKK) for degradation 35 . The early kinetics of macroautophagy activation in T cells and the relatively late activation of CMA suggest that these processes may have distinct roles during T cell activation, as it has been shown in other systems 36 . Consistent with the late kinetics of CMA activation, we did not detect any defect in early signaling events in CMA-deficient T cells. Our data support the proposal that the maintenance of activation-induced T cell responses by CMA can be explained by the selective degradation of Itch and RCAN1. These proteins have been described as negative regulators of TCR signaling, which would explain the need for a tight npg regulation of their cellular abundance to maintain T cell activation 37 . Mice deficient in Itch develop a systemic progressive autoimmune disease with hyperactive T cells 38 . Anergic T cells also upregulate the expression of Itch, which targets the signaling protein PLC-γ and the kinase PKC-θ for degradation 39 . Other proteins inactivated by Itch in T cells include the transcription factor JunB and the TCRζ chain, which defines this E3 ubiquitin ligase as a negative regulator of TCR signaling 38, 40 . Itch activity is regulated by tyrosine phosphorylation mediated by the kinase Fyn 41 . Although degradation as a regulatory mechanism of Itch activity has not been described in T cells, it has been proposed for other E3 ubiquitin ligases that regulate T cell activation, such as Cbl-b 42 . RCAN1 is an inhibitor of calcineurin that contributes to setting the threshold for TCR activation and modulates calcineurin signaling-dependent gene expression 43 . RCAN1 expression increases following engagement of the TCR 26 . A feedback loop occurs in which NFAT2 activates RCAN1 expression, which in turns modulates NFAT activation by controlling calcineurin activity 44 . Our results support the proposal of a model in which CMA would participate in this loop through the regulated degradation of RCAN1, preventing its accumulation, which otherwise could potentially lead to uncontrolled inhibition of calcineurin activity.
Although the increased CMA activity that followed engagement of the TCR could account for the increased degradation of Itch and RCAN1, we cannot exclude the possibility that post-translational modifications might also contribute to this effect, either by creating new CMA motifs or by inducing conformational changes that might expose otherwise hidden CMA motifs 45 . It is also possible that CMA might regulate the degradation of other regulatory proteins in activated T cells. In this sense, CMA modulates the cytosolic abundance of IκB, and inhibitor of the transcription factor NF-κB, in response to nutritional stress in fibroblasts 46 .
CMA activity decreases with age in various tissues due to a gradual reduction in the lysosomal abundance of LAMP-2A, which leads to the accumulation of damaged proteins and inefficient responses to stress 8, 29 . In a mouse transgenic model, restoration of LAMP-2A expression in liver in old mice has been shown to result in decreased signs of cell damage and improved hepatic function 12 . In the aging immune system, the immunosenescent phenotype is particularly evident in the T cell compartment. Several mechanisms have been proposed to account for the decreased efficacy of T cell responses with age, from defects in signaling pathways and formation of immunological synapses to the inability to maintain chromosomal integrity [47] [48] [49] . We found that old T cells also were less able to upregulate LAMP-2A expression and thus our results support the proposal that this dysfunction is not just a consequence of aging but contributes to the deficient T cell responses associated with age, as activation-induced responses were markedly improved when expression of LAMP-2A was restored in T cells from old mice. Decreased upregulation of TCRinduced LAMP-2A expression with age was very clear in naive cells from mice and humans. However, while memory CD4 + T cells from young and old mice showed a similar capacity to increase LAMP-2A expression, upregulation of LAMP-2A expression was clearly deficient in memory T cells from old humans. Although the reasons for this discrepancy between mice and humans remain to be determined, it might reflect the fact that memory T cell responses acquired early in life seem to be conserved in mice 49 , while they are deficient in humans 50 . However, the fact that basal levels of Itch and RCAN1 were much lower in memory CD4 + T cells than in naive CD4 + T cells could indicate that in memory T cells, CMA might be less important in eliminating those proteins, whose abundance in the cell might be reduced during the generation of memory. We propose a model in which TCR-induced generation of ROS upregulates LAMP-2A expression, leading to the activation of CMA and the regulated degradation of TCR-signaling inhibitors, which is required to maintain T cell activation. The failure of this process with age would prevent the normal function of this regulatory mechanism, leading to decreased T cell responses. Modulation of CMA activity in T cells could therefore become a therapeutic tool to improve T cell function with age.
METHODS
Methods and any associated references are available in the online version of the paper.
